• 160,000+
  • pengikut
  • ponsel:
    +62 21 5200 392
  • Prof. dr. Yang Ming Shi

    Prof. dr. Yang Ming Shi

    Spesialis Penyakit Kritis & Pengobatan Multiple Organ Dysfunction Syndrome (MODS)

    Spesialisasi: Pengobatan penyakit kritis dan berbagai penyakit kegagalan organ lainnya.


    Profesor Yang Ming Shi adalah seorang ahli terkenal dalam pengobatan perawatan kritis dan memiliki pengalaman yang kaya serta pengetahuan profesional yang mendalam di bidang pengobatan perawatan kritis.

     

    Profesor Yang berkomitmen terhadap pengobatan dan pengelolaan pasien yang sakit kritis. Beliau telah menerbitkan sejumlah besar artikel tentang pengobatan perawatan kritis di jurnal akademis utama dan memberikan kontribusi penting bagi pengembangan bidang ini. Spesialisasinya adalah diagnosis dan pengobatan berbagai penyakit kritis, termasuk syok, gagal napas, sindrom disfungsi organ ganda, dan lain-lain. Pengetahuan dan pengalaman profesionalnya memberikan dukungan kuat untuk perawatan dan pemulihan pasien. Profesor Yang juga telah melakukan banyak upaya dalam melatih dokter-dokter muda. Beliau secara aktif berpartisipasi dalam pengajaran dan bimbingan dan telah melatih sejumlah besar dokter terkemuka di bidang kedokteran perawatan kritis.


    Daftar Pustaka:

    1. Feizhou,Huang,Huaizheng,Liu,Zhao,Lei,Zhenzhou,Li,Tianyi,Zhang,Mingshi,Yang,Kefu,Zhou,Chuanzheng,Sun.Long noncoding RNA CCAT1 inhibits miR-613 to promote nonalcoholic fatty liver disease via increasing LXRα transcription.[J].Journal of cellular physiology,2020,235(12):9819-9833.DOI:10.1002/jcp.29795.

    2. Feizhou Huang,Huaizheng Liu,Zhao Lei,Zhenzhou Li,Tianyi Zhang,Mingshi Yang,Kefu Zhou,Chuanzheng Sun.Long noncoding RNA CCAT1 inhibits miR-613 to promote nonalcoholic fatty liver disease via increasing LXRα transcription[J].Journal of cellular physiology.,2020,235(12):9819-9833.

    3. Zhiling,Li,Mingshi,Yang,Yue,Peng,Min,Gao,Bingchang,Yang.Rutaecarpine ameliorated sepsis-induced peritoneal resident macrophages apoptosis and inflammation responses.[J].Life sciences,2019,228:11-20.DOI:10.1016/j.lfs.2019.01.038.

    4. Zhiling Li,Mingshi Yang,Yue Peng,Min Gao,Bingchang Yang.Rutaecarpine ameliorated sepsis-induced peritoneal resident macrophages apoptosis and inflammation responses[J].Life sciences,2019,228:11-20.

    5. Hao,Ou,Xianzhong,Xiao,Yu,Jiang,Yue,Peng,Mingshi,Yang,Min,Gao.Expression of microRNA-23b in patients with sepsis and its effect on leukocytes and the expression of E-selectin and ICAM-1.[J].Experimental and therapeutic medicine,2018,16(6):4707-4711.DOI:10.3892/etm.2018.6759.

    6. Zhiling,Gao, Ming,Yang, Bingchang,Zhang, Huali,Wang, Kangkai,Liu, Zuoliang,Xiao, Xianzhong,Yang, Mingshi.Naringin attenuates MLC phosphorylation and NF-kappa B activation to protect sepsis-induced intestinal injury via RhoA/ROCK pathway[J].Biomedicine & pharmacotherapy =: Biomedecine & pharmacotherapie,2018,103:50-58.

    7. Ou, Hao,Xiao, Xianzhong,Jiang, Yu,Peng, Yue,Yang, Mingshi,Gao, Min.Expression of microRNA-23b in patients with sepsis and its effect on leukocytes and the expression of E-selectin and ICAM-1[J].Experimental and therapeutic medicine,2018,16(6 Pt.A):4707-4711.

    8. Wei,Xing,Lei,Yang,Yue,Peng,Qianlu,Wang,Min,Gao,Mingshi,Yang,Xianzhong,Xiao.Ginsenoside Rg3 attenuates sepsis-induced injury and mitochondrial dysfunction in liver via AMPK-mediated autophagy flux.[J].Bioscience reports,2017,37(4):.DOI:10.1042/BSR20170934.

    9. Yue,Peng,Yu,Jiang,Hao,Ou,Wei,Xing,Mingshi,Yang,Min,Gao.[Role of autophagy in ameliorating sepsis-induced acute lung injury by allicinin in mice].[J].Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences,2017,42(8):899-905.DOI:10.11817/j.issn.1672-7347.2017.08.005.

    10. Yang, Bingchang,Gao, Min,Wang, Kangkai,Jiang, Yu,Peng, Yue,Zhang, Huali,Yang, Mingshi,Xiao, Xianzhong.Intraintestinal administration of ulinastatin protects against sepsis by relieving intestinal damage[J].Journal of Surgical Research: Clinical and Laboratory Investigation,2017,211:70-78.

    11. Lang, Yuejiao,Jiang, Yu,Gao, Min,Wang, Wenmei,Wang, Nian,Wang, Kangkai,Zhang, Huali,Chen, Guangwen,Liu, Ke,Liu, Meidong,Yang, Mingshi,Xiao, Xianzhong.Interleukin-1 Receptor 2: A New Biomarker for Sepsis Diagnosis and Gram-Negative/Gram-Positive Bacterial Differentiation[J].Shock: Molecular, cellular, and systemic pathobiological aspects and therapeutic approaches = The official journal of the Shock Society, the European Shock Society, the Brazilian Shock Society, the International Federation of Shock Societies,2017,47(1):119-124.

    12. Hao,Ou,Shangping,Zhao,Yue,Peng,Xuefei,Xiao,Qianlu,Wang,Huaizeng,Liu,Xianzhong,Xiao,Mingshi,Yang.Comparison of bone marrow tissue- and adipose tissue-derived mesenchymal stem cells in the treatment of sepsis in a murine model of lipopolysaccharide-induced sepsis.[J].Molecular medicine reports,2016,14(4):3862-70.DOI:10.3892/mmr.2016.5694.

    13. Ou, Hao,Zhao, Shangping,Peng, Yue,Xiao, Xuefei,Wang, Qianlu,Liu, Huaizeng,Xiao, Xianzhong,Yang, Mingshi.Comparison of bone marrow tissue- and adipose tissue-derived mesenchymal stem cells in the treatment of sepsis in a murine model of lipopolysaccharide-induced sepsis[J].Molecular medicine reports,2016,14(4 Pt.A):3862-3870.

    14. Ou, Hao,Zhao, Shangping,Peng, Yue,Xiao, Xuefei,Wang, Qianlu,Liu, Huaizeng,Xiao, Xianzhong,Yang, Mingshi.Comparison of bone marrow tissue- and adipose tissue-derived mesenchymal stem cells in the treatment of sepsis in a murine model of lipopolysaccharide-induced sepsis[J].Molecular medicine reports,2016,14(4 Pt.B):3862-3870.

    15. Li, Zhiling,Xiao, Xianzhong,Yang, Mingshi.Asiatic Acid Inhibits Lipopolysaccharide-Induced Acute Lung Injury in Mice[J].Inflammation,2016,39(5):1642-1648.

    16. Chuanzheng,Sun,Xunyang,Liu,Zhongjie,Yi,Xuefei,Xiao,Mingshi,Yang,Gui,Hu,Huaizheng,Liu,Liangkan,Liao,Feizhou,Huang.Genome-wide analysis of long noncoding RNA expression profiles in patients with non-alcoholic fatty liver disease.[J].IUBMB life,2015,67(11):847-52.DOI:10.1002/iub.1442.

    17. Huaizheng,Liu,Zuoliang,Liu,Shangping,Zhao,Chuanzheng,Sun,Mingshi,Yang.Effect of BML-111 on the intestinal mucosal barrier in sepsis and its mechanism of action.[J].Molecular medicine reports,2015,12(2):3101-6.DOI:10.3892/mmr.2015.3746.

    18. Huaizheng,Liu,Xuefei,Xiao,Chuanzheng,Sun,Dao,Sun,Yayong,Li,Mingshi,Yang.Systemic inflammation and multiple organ injury in traumatic hemorrhagic shock.[J].Frontiers in bioscience (Landmark edition),2015,20(6):927-33.DOI:10.2741/4347.

    19. Chuanzheng,Sun,Feizhou,Huang,Xunyang,Liu,Xuefei,Xiao,Mingshi,Yang,Gui,Hu,Huaizheng,Liu,Liangkan,Liao.miR-21 regulates triglyceride and cholesterol metabolism in non-alcoholic fatty liver disease by targeting HMGCR.[J].International journal of molecular medicine,2015,35(3):847-53.DOI:10.3892/ijmm.2015.2076.

    20. Liu, Huaizheng,Liu, Zuoliang,Zhao, Shangping,Sun, Chuanzheng,Yang, Mingshi.Effect of BML-111 on the intestinal mucosal barrier in sepsis and its mechanism of action[J].Molecular medicine reports,2015,12(2 Pt.A):3101-3106.

    21. Liu, Huaizheng,Liu, Zuoliang,Zhao, Shangping,Sun, Chuanzheng,Yang, Mingshi.Effect of BML-111 on the intestinal mucosal barrier in sepsis and its mechanism of action[J].Molecular medicine reports,2015,12(2 Pt.B):3101-3106.

    22. Peng, Yue,Gao, Min,Jiang, Yu,Wang, Kangkai,Zhang, Huali,Xiao, Zihui,Ou, Hao,Yang, Bingchang,Yang, Mingshi,Xiao, Xianzhong.ANGIOGENESIS INHIBITOR ENDOSTATIN PROTECTS MICE WITH SEPSIS FROM MULTIPLE ORGAN DYSFUNCTION SYNDROME[J].Shock: Molecular, cellular, and systemic pathobiological aspects and therapeutic approaches = The official journal of the Shock Society, the European Shock Society, the Brazilian Shock Society, the International Federation of Shock Societies,2015,44(4):357-364.

    23. Huaizheng Liu,Xuefei Xiao,Chuanzheng Sun,Dao Sun,Yayong Li,Mingshi Yang.Systemic inflammation and multiple organ injury in traumatic hemorrhagic shock[J].Frontiers in bioscience: a journal and virtual library,2015,20(Landmark.3):927-933.

    24. Sun, Chuanzheng,Liu, Xunyang,Yi, Zhongjie,Xiao, Xuefei,Yang, Mingshi,Hu, Gui,Liu, Huaizheng,Liao, Liangkan,Huang, Feizhou.Genome-wide Analysis of Long Noncoding RNA Expression Profiles in Patients with Non-Alcoholic Fatty Liver Disease[J].IUBMB life,2015,67(11):847-852.

    25. Jing,Jiao,Min,Gao,Huali,Zhang,Nian,Wang,Zihui,Xiao,Ke,Liu,Mingshi,Yang,Kangkai,Wang,Xianzhong,Xiao.Identification of potential biomarkers by serum proteomics analysis in rats with sepsis.[J].Shock (Augusta, Ga.),2014,42(1):75-81.DOI:10.1097/SHK.0000000000000173.

    26. Shangping,Zhao,Mingshi,Yang.[New treatment for sepsis: stem cell therapy].[J].Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences,2013,38(7):754-60.DOI:10.3969/j.issn.1672-7347.2013.07.017.

    27. 孙子贻,高敏,蒋宇,杨明施.淫羊藿苷对脓毒症小鼠急性肺损伤的作用[J].实用休克杂志(中英文),2021,5(3):146-149,164.

    28. 欧好,彭玥,王仟陆,杨明施,高敏.丹参酮ⅡA对脓毒症急性肺损伤小鼠多糖包被的保护作用[J].实用休克杂志(中英文),2020,4(1):14-18,23.

    29. 靳欣,方毅敏,黄绍华,罗林,秦运检,吴慧,杨明施,艾宇航,彭玥.新型冠状病毒肺炎危重症患者救治中优化管理与呼吸治疗的探索[J].中华重症医学电子杂志(网络版),2020,6(3):344-346.DOI:10.3877/cma.j.issn.2096-1537.2020.03.021.

    30. 刘怀政,孙传政,周柯夫,张天一,杨明施.急诊住院医师的教学查房模式[J].中国继续医学教育,2020,12(12):55-56.DOI:10.3969/j.issn.1674-9308.2020.12.023.

    31. 刘兮,肖雪飞,高敏,杨明施,刘晶晶.HFNC氧疗对重型COVID-19患者呼吸支持的观察研究[J].实用休克杂志(中英文),2020,4(4):203-207.

    32. 李志凌,欧好,刘作良,刘晶晶,肖雪飞,杨明施,彭玥.急诊教学中以医学生为主体的急救普及模式探讨[J].实用休克杂志(中英文),2019,3(6):343-346.

    33. 高敏,彭玥,刘作良,肖雪飞,杨明施,欧好.医学生作为心肺复苏培训导师的急救普及教育探讨[J].实用休克杂志(中英文),2019,3(5):291-293.

    34. 刘作良,杨明施,龙燕琼,仇向东,岳阳,张胜南.简易持续负压引流装置在大量渗出性伤口中的应用[J].中国急救复苏与灾害医学杂志,2017,12(6):584-586.DOI:10.3969/j.issn.1673-6966.2017.06.027.

    35. 赵尚平,欧好,彭玥,许春,刘作良,杨明施,肖雪飞.局部枸橼酸钠抗凝技术在ICU肝功能障碍患者连续静脉-静脉血液滤过治疗中的应用研究[J].中国急救医学,2017,37(4):330-334.DOI:10.3969/j.issn.1002-1949.2017.04.011.

    36. 刘作良,李世忠,龙燕琼,肖为,田魁,杨明施.湖南省院前急救现状调查分析[J].中华急诊医学杂志,2015,24(10):1101-1103.DOI:10.3760/cma.j.issn.1671-0282.2015.10.011.

    37. 赵尚平,肖雪飞,欧好,彭玥,刘作良,王仟陆,杨明施.骨髓间充质干细胞对脓毒症小鼠急性肺损伤的影响[J].中国急救医学,2015,35(11):973-976.DOI:10.3969/j.issn.1002-1949.2015.11.003.

    38. 刘晶晶,杨明施,袁洪.N-末端脑钠肽前体对ICU老年危重病患者预后的预测价值[J].中国老年学杂志,2015,(11):3049-3051.DOI:10.3969/j.issn.1005-9202.2015.11.079.

    39. 焦京,蒋宇,高敏,王念,杨明施,肖献忠.脂多糖结合蛋白在脓毒症患者诊断和预后预测中的作用[J].中国病理生理杂志,2015,(7):1294-1299.DOI:10.3969/j.issn.1000-4718.2015.07.025.

    40. 肖雪飞,杨明施,孙圣华.姜黄素对脓毒症急性肺损伤的炎症反应及NF-κB信号通路的影响[J].中国现代医学杂志,2013,23(30):19-22.

    41. 赵尚平,杨明施.脓毒症治疗的新希望:干细胞疗法[J].中南大学学报(医学版),2013,(7):754-760.DOI:10.3969/j.issn.1672-7347.2013.07.017.

    42. 刘作良,杨明施.血必净对重症急性胰腺炎大鼠热休克蛋白70的影响[J].中华急诊医学杂志,2012,21(2):180-183.DOI:10.3760/cma.j.issn.1671-0282.2012.02.018.

    43. 万齐全,杨明施,叶启发,马颖.21例肾移植术后近期肺部感染并急性呼吸窘迫综合征患者救治经验[J].中日友好医院学报,2010,24(5):281-285,封3.DOI:10.3969/j.issn.1001-0025.2010.05.008.

    44. 万齐全,杨明施,肖雪飞,杨兵厂.有创与无创序贯通气疗法在COPD急性加重患者中的应用[J].医学临床研究,2009,26(10):1830-1833.DOI:10.3969/j.issn.1671-7171.2009.10.018.

    45. 万齐全,杨明施,肖雪飞,叶启发,马颖,杨兵厂.肝移植术后谷氨酰胺的应用[J].中国普通外科杂志,2008,17(7):636-640.DOI:10.3969/j.issn.1005-6947.2008.07.003.

    46. 杨明施,马朋林,陈德昌.白细胞介素-1家族细胞因子等位基因对相关细胞因子的产生及全身感染预后的影响[J].中国危重病急救医学,2005,17(4):203-206.DOI:10.3760/j.issn:1003-0603.2005.04.004.

    47. 万齐全,杨明施,马颖.肝移植术后严重感染状态下的严重排斥反应3例报告[J].中国普通外科杂志,2005,14(2):159-160.DOI:10.3969/j.issn.1005-6947.2005.02.025.

    48. 杨明施,邢伟,彭玥,刘作良.呼吸机相关性肺炎的临床分析[J].中国现代医学杂志,2003,13(18):116-117,119.DOI:10.3969/j.issn.1005-8982.2003.18.040.

    49. 刘浔阳,朱晒红,黄飞舟,聂晚频,刘波,李瑞珍,商中华,黄东,杨明施,任树平.无创性食管曲张静脉测压仪研制[J].生物医学工程与临床,2001,5(2):61-64.DOI:10.3969/j.issn.1009-7090.2001.02.001.

     

    Prestasi dan Pencapaian Akademik:

    ● Memperoleh empat paten model utilitas nasional.

    ● Melakukan 8 proyek penelitian ilmiah provinsi.

    ● Pada bulan April 2020, Departemen Sumber Daya Manusia dan Jaminan Sosial Provinsi Hunan, Komisi Kesehatan Provinsi, dan Administrasi Pengobatan Tradisional Tiongkok Provinsi bersama-sama mengeluarkan "Keputusan untuk Memuji Individu yang Maju dalam Pencegahan dan Pengendalian Epidemi COVID-19 di Provinsi", memberikan penghargaan kontribusi besar kepada Saudari Yang Mingshi.

     

    Penunjukan Editorial dan Akademik:

    ● Berpartisipasi dalam penyusunan buku “Praktik Klinis Kardiologi” sebagai wakil pemimpin redaksi

    ● Menjabat sebagai anggota National Society of Pathophysiology dan anggota National Society of Critical Care Medicine

    ● Wakil Ketua Masyarakat Kedokteran Perawatan Kritis Provinsi Hunan

    ● Wakil Ketua Komite Profesional Pengendalian Mutu ICU Provinsi Hunan



    Isi formulir untuk menghubungi kami dengan cepat

    Kami akan bekerja sama dengan rumah sakit dan spesialis terkemuka untuk memberi Anda layanan medis lintas batas berkualitas tinggi


    Laporan Medis*:
    Hubungi kami*:

    Copyright @Rumah Sakit Jing Kai Sa All Rights Reserved.  
    粤ICP备14008526号 

    Peta Situs